CN104740179B - A kind of Chinese medicine composition for treating central retinal artery occlusion - Google Patents
A kind of Chinese medicine composition for treating central retinal artery occlusion Download PDFInfo
- Publication number
- CN104740179B CN104740179B CN201510094234.1A CN201510094234A CN104740179B CN 104740179 B CN104740179 B CN 104740179B CN 201510094234 A CN201510094234 A CN 201510094234A CN 104740179 B CN104740179 B CN 104740179B
- Authority
- CN
- China
- Prior art keywords
- grams
- rhizoma
- radix
- chinese medicine
- artery occlusion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 201000007527 Retinal artery occlusion Diseases 0.000 title claims abstract description 21
- 201000005849 central retinal artery occlusion Diseases 0.000 title claims abstract description 21
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 12
- 235000007516 Chrysanthemum Nutrition 0.000 claims abstract description 12
- 241000218176 Corydalis Species 0.000 claims abstract description 12
- 241000246500 Gentianella aspera Species 0.000 claims abstract description 12
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 12
- 239000009636 Huang Qi Substances 0.000 claims abstract description 12
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 12
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 12
- 241000361919 Metaphire sieboldi Species 0.000 claims abstract description 12
- 244000179560 Prunella vulgaris Species 0.000 claims abstract description 12
- 235000010674 Prunella vulgaris Nutrition 0.000 claims abstract description 12
- 241000405414 Rehmannia Species 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 11
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 claims abstract description 8
- 235000000802 Leonurus cardiaca ssp. villosus Nutrition 0.000 claims abstract description 8
- 244000197580 Poria cocos Species 0.000 claims abstract description 8
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 8
- 241000489492 Arisaema Species 0.000 claims abstract description 5
- 241000255789 Bombyx mori Species 0.000 claims abstract description 5
- 241001522129 Pinellia Species 0.000 claims abstract description 5
- 240000002924 Platycladus orientalis Species 0.000 claims abstract description 5
- 241000157352 Uncaria Species 0.000 claims abstract description 5
- 210000000941 bile Anatomy 0.000 claims abstract description 5
- 241000723353 Chrysanthemum Species 0.000 claims description 11
- 235000019640 taste Nutrition 0.000 claims description 9
- 241000207925 Leonurus Species 0.000 claims 4
- 230000000694 effects Effects 0.000 abstract description 7
- 210000004185 liver Anatomy 0.000 abstract description 7
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 208000002173 dizziness Diseases 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 206010019233 Headaches Diseases 0.000 abstract description 3
- 240000006079 Schisandra chinensis Species 0.000 abstract description 3
- 235000008422 Schisandra chinensis Nutrition 0.000 abstract description 3
- 231100000869 headache Toxicity 0.000 abstract description 3
- 208000001344 Macular Edema Diseases 0.000 abstract description 2
- 206010025415 Macular oedema Diseases 0.000 abstract description 2
- 206010062519 Poor quality sleep Diseases 0.000 abstract description 2
- 244000126002 Ziziphus vulgaris Species 0.000 abstract description 2
- 239000002253 acid Substances 0.000 abstract description 2
- 230000001914 calming effect Effects 0.000 abstract description 2
- 201000010230 macular retinal edema Diseases 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 230000004438 eyesight Effects 0.000 description 16
- 210000001525 retina Anatomy 0.000 description 9
- 210000004204 blood vessel Anatomy 0.000 description 8
- 206010030113 Oedema Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 210000001367 artery Anatomy 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 238000002577 ophthalmoscopy Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000004446 light reflex Effects 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 240000007890 Leonurus cardiaca Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 201000004569 Blindness Diseases 0.000 description 2
- 241000167854 Bourreria succulenta Species 0.000 description 2
- 208000006550 Mydriasis Diseases 0.000 description 2
- 208000002367 Retinal Perforations Diseases 0.000 description 2
- 206010038897 Retinal tear Diseases 0.000 description 2
- 239000002220 antihypertensive agent Substances 0.000 description 2
- 229940127088 antihypertensive drug Drugs 0.000 description 2
- 235000019693 cherries Nutrition 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 108010027612 Batroxobin Proteins 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 208000002087 Endarteritis Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 1
- 239000000006 Nitroglycerin Substances 0.000 description 1
- 206010033546 Pallor Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 229960001138 acetylsalicylic acid Drugs 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 229960002768 dipyridamole Drugs 0.000 description 1
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960003711 glyceryl trinitrate Drugs 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 229960005356 urokinase Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of Chinese medicine compositions for treating central retinal artery occlusion, are made of following bulk pharmaceutical chemicals：20 grams of Radix Astragali, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, 10 grams of Schisandra chinensis, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, 12 grams of chrysanthemum.Dialectical plus-minus：Headache and dizzy person adds 12 grams of Rhizoma Gastrodiae, 10 grams of uncaria, with calming the liver to stop the wind；Macular edema seriously adds 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort, with the Li Shui that dehumidifies；The greasy slippery person of tongue adds 10 grams of stiff silkworm, 12 grams of the tuber of pinellia, 10 grams of arisaema cum bile with eliminating dampness and eliminating phlegm.15 grams of poor sleep acid adding jujube kernel, 12 grams of the seed of Oriental arborvitae are with mental-tranquilization.Pure Chinese medicine of the present invention is produced, and toxic side effect is small.
Description
Technical field
The present invention relates to a kind of Chinese medicine compositions for treating central retinal artery occlusion, belong to technical field of traditional Chinese medicines.
Background technology
Central retinal artery occlusion is caused in retina due to vasopasm, thrombosis and external compressing etc.
Layer blood supply is obstructed, and the acute ischemia of retina, eyesight degradation are caused.Central retinal artery occlusion is to cause to blind suddenly
One of acute disease, caused due to arteriospasm, embolic infarction, endarteritis or atherosclerosis etc..Treatment is available
Blood vessel dilatation drug carries out emergency treatment, sucks isoamyl nitrite or sublingual administration nitroglycerin immediately.To being suspected to have thrombus shape
At or the patient that increases of fibrinogen can apply Fibrinolytic agent.Urokinase is slowly injected in intravenous drip；Or it is quiet with defibrase
Arteries and veins drop.Also the platelet suppressors such as orally available aspirin, Dipyridamole and blood-activating and stasis-removing.These Western medicine majorities are to face
Bed first aid drug, takes effect than very fast, but its is palliative, without fundamentally improving the blood circulation shape of retina
Condition.Chinese medicine improves Microcirculation for Treatment central retinal artery occlusion, achieves certain effect, obtain by activating blood circulation and dispersing blood clots
Vast central retinal artery occlusion patient approves.
Invention content
The purpose of the present invention is to provide a kind of Chinese medicine compositions for treating central retinal artery occlusion.
The purpose of the present invention is what is realized by following scheme：A kind of Chinese traditional medicine composition for treating central retinal artery occlusion
Object is made of following bulk pharmaceutical chemicals：20 grams of Radix Astragali, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, earthworm 15
Gram, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, 10 grams of Schisandra chinensis, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, radix scutellariae 12
Gram, 15 grams of rough gentian, 12 grams of Prunella vulgaris, 12 grams of chrysanthemum.Dialectical plus-minus：Headache and dizzy person adds 12 grams of Rhizoma Gastrodiae, 10 grams of uncaria, with soothing the liver
Relieve dizziness, high fever, infantile convulsions, epilepsy, etc.；Macular edema seriously adds 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort, with the Li Shui that dehumidifies；The greasy slippery person of tongue, adds deadlock
10 grams of silkworm, 12 grams of the tuber of pinellia, 10 grams of arisaema cum bile are with eliminating dampness and eliminating phlegm.15 grams of poor sleep acid adding jujube kernel, 12 grams of the seed of Oriental arborvitae are pacified with nourishing heart
God.
Application method：It is decocted in water for oral dose, one dose per day, a point early, evening takes twice, 10 days courses for the treatment of.
Chinese medicine thinks this disease mostly because of emotional maladjustment, qi depression to blood stasis；Or the deficiency of vital energy is insufficient, promoting circulation of blood is powerless, stagnation of QI-blood；Or overfeeding
Delicious food, the dysfunction of the spleen in transport, Phlegm to hinder collaterals；Or hyperactivity of yang due to yin deficiency, it moves in irascibility, above disturbs clear key, upward invasion of liver-QI, closing train of thought etc. all may be used
Make qi-blood disharmony, intraocular blood network stasis blocking, malnutrition of eyes and send out this disease.Treatment is lived with qi and activate blood circulation, enriching yin nourishing the liver, dispersing stagnated hepatoqi
Based on blood stagnation resolvation.Diagnosis and treatment：Headache and dizzy person, hot-tempered guerulent are mostly liver wind agitation；Body is fat, and the greasy slippery person of tongue is phlegm
Turbid resistance network；Oedema is seriously that damp and hot cross is contained.
In inventive formulation, Radix Astragali, Rhizoma Atractylodis Macrocephalae, Radix Glycyrrhizae tonifying middle-Jiao and Qi；When angelica tail, Semen Leonuri, earthworm, Rhizoma Chuanxiong are promoting blood circulation and removing blood stasis；
Prepared rehmannia root, Schisandra chinensis, matrimony vine Yin-nourishing and body fluid promoting, nourish the liver to improve visual acuity；Radix bupleuri, rhizoma cyperi, corydalis tuber dispersing stagnated hepatoqi；Radix scutellariae, rough gentian, Prunella vulgaris,
Chrysanthemum is clearing heat and detoxicating.Rhizoma Gastrodiae, uncaria are calming the liver to stop the wind；Poria cocos, rhizoma alismatis, motherwort dehumidifying Li Shui；Stiff silkworm, the tuber of pinellia, arisaema cum bile eliminating dampness
Resolving sputum；Spina date seed, seed of Oriental arborvitae mental-tranquilization.Above-mentioned all medicine compatibilities play qi and activate blood circulation altogether, nourishing kidney yin, promoting blood circulation and removing obstruction in channels, heat-clearing are put out
The effect of wind, flat liver improving eyesight.It treats in conjunction with illness is dialectical, the work for the treatment of both manifestation and root cause of disease is played to treatment central retinal artery occlusion
With.
Pure Chinese medicine of the present invention is produced, and toxic side effect is small.
Specific implementation mode
With reference to embodiment, the invention will be further described.
Embodiment 1：A kind of Chinese medicine composition for treating central retinal artery occlusion, is made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams.
Embodiment 2：A kind of Chinese medicine composition for treating central retinal artery occlusion, is made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 12 grams of Rhizoma Gastrodiae, 10 grams of uncaria.
Embodiment 3：A kind of Chinese medicine composition for treating central retinal artery occlusion, is made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort.
Embodiment 4：A kind of Chinese medicine composition for treating central retinal artery occlusion, is made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 10 grams of stiff silkworm, 12 grams of the tuber of pinellia, 10 grams of arisaema cum bile.
Embodiment 5：A kind of Chinese medicine composition for treating central retinal artery occlusion, is made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 15 grams of spina date seed, 12 grams of the seed of Oriental arborvitae.
Clinical data
1, basic document.
Our hospital's in January, 2013 in January, 2014 accepts central retinal artery occlusion patient 46 for medical treatment, is all made of in the present invention
Medicine carries out treatment observation.Wherein man 32, female 14；Age is 36 years old minimum, 71 years old maximum, 56 years old average；Right eye 26, left eye
20；The course of disease most short person 2 hours, most elder 24 hours.Seen in checking：Eyesight is faint.Mydriasis, direct light reflex subtract
Weak or disappearance, indirect light reflex exist, the greyish white muddy oedema of retina, macular area cherry red spot.2 therapies.Necessary elder generation
Emergency treatment is carried out with blood vessel dilatation drug, Chinese medicine of the present invention is then given, is decocted in water for oral dose, one dose per day.Seen after treating 20 days
Examine effect.It is eyesight >=1.0 that 3 observation of curative effect, 3.1 criterion of therapeutical effect, which is cured, and optical fundus blood vessel restores normal；It is effective to be carried for eyesight
High >=3 row, optical fundus blood vessel are restored；It is that eyesight improves 1~2 row to improve, and optical fundus blood vessel has recovery：In vain for eyesight without change
Change.Treatment of 3.2 treatment results Jing Guo 2 courses for the treatment of, healing 31, effective 9, effective 6, total effective rate 100%.
Model case
Case 1：Patient Zhang, man are 63 years old, medical to our hospital's ophthalmology on October 20th, 2013.Main suit：Right eye is unexpected
Eye-blurred, the visual field reduce.Eye examination：Eyesight：Right eye 0.3, left eye 1.0.Right eye direct light reflex is blunt, indirect light reflex
Normally, binocular lense is transparent, and vitreum is without muddiness.Funduscopy：Right eye pallor papillae, arter centralis retinae attenuate, breast
Head temporo side view nethike embrane kermesinus, peripheral retinal tear are in canescence oedema, and left funduscopy is normal.Diagnosis：Retina of right eye center
Obstruction of artery.Emergency treatment first is carried out with blood vessel dilatation drug, Chinese medicine of the present invention is given, is decocted in water for oral dose, one dose per day is taken 10 days
Afterwards, right eye perspective restores normal, and eyesight is increased to 0.6 by 0.3, and 10 days eyesight right eyes of continual cure are restored to 1.0, view film water
Swollen to disappear, optical fundus blood vessel restores normal flow direction.
Case 2：Patient's Mr. Bai, female, 53 years old, on June 22nd, 2013, right eye suddenly be hospitalized by blindness.Eye examination：Left eye regards
Power：No light perception, right vision：1.0.Cornea of left eye mydriasis disappears to light reflection.Right eye is normal.Funduscopy：Left eye regards
Nethike embrane canescence oedema, arter centralis retinae obviously attenuate, and macular area is in cherry erythema.Right eye is normal.Blood pressure 165/
100mmhg.Diagnosis：Retina of left eye central artery blocks.Emergency treatment first is carried out with blood vessel dilatation drug, then gives the present invention
Chinese medicine is decocted in water for oral dose, one dose per day, while taking antihypertensive drugs, and after taking 10 days, left vision is restored, sight slightly mould
Paste, eyesight testing 0.4,20 days vision restorations of continual cure to 1.0, retina is red and swollen, spot disappears, recovery from illness discharge.Pay a return visit nothing
Recurrence.
Case 3：Patient field so-and-so, female, 48 years old, on May 6th, 2013, the visual field, which becomes smaller, came institute because of left eye unexpected blurred vision
Treatment.Eye examination：Left vision 0.2, right eye 1.0, funduscopy:Retina of left eye nipple is pale, and oedema obscurity boundary is not
Clearly, central artery attenuates, nipple temporo side view nethike embrane kermesinus, and foveal reflex disappears, and peripheral retinal tear is in canescence oedema,
Right funduscopy is normal, there is hypertension history.It is diagnosed as retina of left eye central artery obstruction.To Chinese medicine of the present invention, it is decocted in water for oral dose,
One dose per day, while antihypertensive drugs is taken, after continuously taking 10 days, left vision is increased to 0.5, and 10 days left eyes of continual cure regard
Power is restored to 0.8, and the infiltration of view oedema is controlled.
Claims (4)
1. a kind of Chinese medicine composition for treating central retinal artery occlusion, which is characterized in that be made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort.
2. a kind of Chinese medicine composition for treating central retinal artery occlusion, which is characterized in that be made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort, 12 grams of Rhizoma Gastrodiae, 10 grams of uncaria.
3. a kind of Chinese medicine composition for treating central retinal artery occlusion, which is characterized in that be made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort, 10 grams of stiff silkworm, 12 grams of the tuber of pinellia, 10 grams of arisaema cum bile.
4. a kind of Chinese medicine composition for treating central retinal artery occlusion, which is characterized in that be made of following bulk pharmaceutical chemicals：Radix Astragali
20 grams, 15 grams of Rhizoma Atractylodis Macrocephalae, 12 grams of Radix Glycyrrhizae, when 20 grams of angelica tail, 12 grams of Semen Leonuri, 15 grams of earthworm, 6 grams of Rhizoma Chuanxiong, 15 grams of prepared rehmannia root, the five tastes
10 grams of son, 15 grams of matrimony vine, 15 grams of radix bupleuri, 12 grams of rhizoma cyperi, 10 grams of corydalis tuber, 12 grams of radix scutellariae, 15 grams of rough gentian, 12 grams of Prunella vulgaris, chrysanthemum
12 grams, 12 grams of Poria cocos, 12 grams of rhizoma alismatis, 10 grams of motherwort, 15 grams of spina date seed, 12 grams of the seed of Oriental arborvitae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510094234.1A CN104740179B (en) | 2015-03-03 | 2015-03-03 | A kind of Chinese medicine composition for treating central retinal artery occlusion |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510094234.1A CN104740179B (en) | 2015-03-03 | 2015-03-03 | A kind of Chinese medicine composition for treating central retinal artery occlusion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104740179A CN104740179A (en) | 2015-07-01 |
| CN104740179B true CN104740179B (en) | 2018-10-26 |
Family
ID=53580800
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510094234.1A Expired - Fee Related CN104740179B (en) | 2015-03-03 | 2015-03-03 | A kind of Chinese medicine composition for treating central retinal artery occlusion |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104740179B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105477204A (en) * | 2016-01-11 | 2016-04-13 | 高淼淼 | Composition for adjuvant treatment on occlusion of central retinal artery and preparing method of composition |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103860764A (en) * | 2014-03-12 | 2014-06-18 | 逄增容 | Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof |
-
2015
- 2015-03-03 CN CN201510094234.1A patent/CN104740179B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103860764A (en) * | 2014-03-12 | 2014-06-18 | 逄增容 | Traditional Chinese medicine for treating central retinal artery obstruction and preparation method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 中医辨证论治视网膜中央动脉阻塞55例疗效观察;张祖海;《中国现代医生》;20090928;第47卷(第27期);第86页 * |
| 活血通络治疗视网膜动脉阻塞61例;张铭连等;《辽宁中医杂志》;19961018;第23卷(第10期);第456页右栏第1段 * |
| 葛根素注射液联合血府逐瘀汤治疗视网膜中央动脉阻塞30例临床观察;陈燕;《中国中医急症》;20090415;第18卷(第04期);第549页右栏第1段 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104740179A (en) | 2015-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102631558B (en) | Medicament for treating eye disease and preparation method of medicament | |
| CN1066945C (en) | Chinese drug Mingmudan pill for improving eyesight and its producing method | |
| CN102626449A (en) | Capsule for treating apoplexy hemiplegia | |
| CN102631557B (en) | Traditional Chinese medicine composition for treating cataract, external oculopathy, presbyopia and myopia and preparation method thereof | |
| CN104740179B (en) | A kind of Chinese medicine composition for treating central retinal artery occlusion | |
| CN103720857A (en) | Traditional Chinese medicinal preparation for treating fundus macular oedema lesion | |
| CN103585363A (en) | Traditional Chinese medicine composition for treating senile cataract | |
| CN103830552A (en) | Traditional Chinese medicine composition for treating Meniere's disease | |
| CN104587257A (en) | Traditional Chinese medicine composition for treating diabetic macular edema | |
| CN108186749A (en) | Treat Chinese medicine composition of cervical spondylosis and preparation method thereof | |
| CN1056292C (en) | Eyesight granule and its compounding process | |
| CN104523981A (en) | Traditional Chinese medicine preparation for treating optic neuritis and preparation method | |
| CN102755549B (en) | Drug for curing cataract and preparation method thereof | |
| CN1162454A (en) | Green bamboo liquid for fumigation of eyes and preparation thereof | |
| CN105343506A (en) | Method for preparing composition for treating type-2 diabetes | |
| CN101288708A (en) | Chinese medicinal preparation for treating ophthalmic vertigo | |
| CN104306546A (en) | A traditional Chinese medicine composition used for treating optic atrophy, and decoctions, pills and powder of the composition | |
| CN102225105B (en) | Medicine for treating migraine | |
| CN103908627A (en) | Traditional Chinese medicine preparation for treating central retinal vein occlusion | |
| CN106110009A (en) | One treats cataractous Chinese medicine preparation and preparation method | |
| CN115444903A (en) | Application of rehabilitation eyesight oral liquid in preparation of eyesight improving medicine | |
| CN104474289A (en) | Traditional Chinese medicine eye drops for treating ocular inflammation and preparation method thereof | |
| CN105726984A (en) | Traditional Chinese medicine eye drops for treating eye inflammation and preparation method thereof | |
| CN105477067A (en) | Traditional Chinese medicine composition for treating dampness obstructing spleen-stomach type infantile jaundice | |
| CN105288290A (en) | Method for preparing traditional Chinese medicine for control of blurred vision |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB03 | Change of inventor or designer information | ||
| CB03 | Change of inventor or designer information |
Inventor after: Yang Bo Inventor before: Liang Tianqi |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20171116 Address after: The Yellow River high tech Zone of Shandong Province, Liaocheng City Road 252000 No. 16 Chong Building 3 single room 1601 Applicant after: Yang Bo Address before: 252000 Guangming ophthalmology hospital, No. 87 Changrun North Road, Dongchangfu District, Liaocheng City, Shandong Province Applicant before: Liang Tianqi |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20180913 Address after: 610000 No. 132 Huatai four road, Wuhou District, Chengdu, Sichuan Applicant after: Sichuan and Guang Tang Biotechnology Co., Ltd. Address before: 252000 Shandong science and technology building, Liaocheng high tech Zone, the Yellow River 16, 3 Chuang 1601 room Applicant before: Yang Bo |
|
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20181026 Termination date: 20190303 |